Synta Pharmaceuticals Corp. (NASDAQ: SNTA) announced presentation of interim results from the ENCHANT-1 trial, a single-arm multi-center Phase 2 proof-of-concept study designed to evaluate ganetespib, the Company’s lead drug candidate, administered as monotherapy for the treatment of metastatic breast cancer. The results are being presented today in an oral session at the 9(th) European Breast Cancer Conference (EBCC) in Glasgow, Scotland at 9:45 AM local time. Synta Pharmaceuticals Corp. (NASDAQ:SNTA) stock opened today at $5.43 and is currently trading at $5.29. The stock showed a positive weekly performance of 4.40%.
The MannKind Corporation (NASDAQ:MNKD) company on Feb. 18 reported financial results for the fourth quarter and full year ended December 31, 2013. The net loss applicable to common stockholders for fiscal year 2013 was $(191.5) million, or $(0.64) per share based on 299.6 million weighted average shares outstanding, compared with a net loss applicable to common stockholders of $(169.4) million, or $(0.94) per share based on 180.9 million weighted average shares outstanding for fiscal year 2012. The number of common shares outstanding at December 31, 2013 was 369,391,972. MannKind Corporation (NASDAQ:MNKD) stock opened at $5.84, in current trading session and currently is at $5.91, by gaining 3.87%.The 52 week range of $3.27-$8.70. Company’s market capitalization is $2.23 billion.
Hanwha Solarone Co Ltd (NASDAQ:HSOL), is a top-10 global photovoltaic (“PV”) manufacturer of high-quality, cost-competitive solar modules, today announced it has signed a memorandum of understanding (“MOU”) with the Wuxi New District Administrative Committee (the “Wuxi Administrative Committee”) to establish a long-term strategic partnership to develop downstream PV projects. The Wuxi Administrative Committee will provide rooftop space, facilitate local government approvals and grid connection, as well as, aid with obtaining preferential tax treatment and project financing. As part of the strategic partnership, Hanwha SolarOne intends to own and operate 100 MW of distributed generation projects in Wuxi New District. Hanwha Solarone Co Ltd (NASDAQ:HSOL) stock is currently trading at $3.80 .The EPS of the stock is -2.91. Company’s market capitalization is $321.83 million.
Avanir Pharmaceuticals, Inc. (NASDAQ: AVNR) announced the publication of data showing that dextromethorphan has antidepressant-like effects in vivo. The study, published in PLOS ONE, an international, peer-reviewed, open-access medical journal, examined the antidepressant activity of dextromethorphan and the potential involvement of sigma-1 receptors. Avanir Pharmaceuticals Inc (NASDAQ:AVNR) stock opened the session at $4.03, and now is at $4.00. The 52 week range of the AVNR stock remained $2.60-$6.00 and the day range was $3.87-$4.04.
Leave a Reply